Table 1.
Nasal Epithelial Lining Fluid (NELF) | ||||||||
---|---|---|---|---|---|---|---|---|
Days Post Diagnosis | IgA | 0–4 | 5–9 | 12–16 | 19–23 | 26–30 | 83–99 | 169–197 |
Symptomatic paediatric patients | n | 17 | 19 | 19 | 18 | 17 | 16 | 15 |
Median ± IQR | 0.7 ± 0.13 | 1.5 ± 3.1 | 8.2 ± 12.7 | 7.7 ± 8.8 | 8.3 ± 10.7 | 3.1 ± 5.6 | 1.8 ± 2.4 | |
% | 35 | 63 | 95 | 89 | 94 | 88 | 53 | |
Adult patients with mild disease | n | 13 | 17 | 18 | 15 | 14 | 10 | 8 |
Median ± IQR | 0.3 ± 1.7 | 1.1 ± 4.0 | 3.4 ± 5.5 | 4.7 ± 6.7 | 5.9 ± 8.5 | 1.1 ± 4.2 | 1.7 ± 3.9 | |
% | 31 | 47 | 89 | 93 | 93 | 50 | 63 | |
Mann-Whitney test between groups | 0.3203 | 0.2676 | 0.1701 | 0.1004 | 0.2619 | 0.1089 | 0.8746 | |
Fisher’s Exact test between groups | ns | 0.5027 | 0.6039 | ns | ns | 0.0687 | ns | |
IgG | ||||||||
Symptomatic paediatric patients | n | 16 | 18 | 18 | 18 | 17 | 16 | 15 |
Median ± IQR | 0.1 ± 0.0 | 0.1 ± 0.1 | 0.2 ± 0.2 | 0.5 ± 1.2 | 0.6 ± 1.0 | 0.4 ± 0.8 | 0.2 ± 0.3 | |
% | 0 | 0 | 0 | 28 | 24 | 19 | 7 | |
Adult with mild disease | n | 10 | 10 | 10 | 10 | 9 | 8 | 7 |
Median ± IQR | 0.1 ± 0.1 | 0.1 ± 0.1 | 0.1 ± 1.0 | 0.2 ± 0.2 | 0.6 ± 0.8 | 0.1 ± 0.3 | 0.1 ± 0.1 | |
% | 0 | 0 | 20 | 0 | 11 | 0 | 0 | |
Mann-Whitney test between groups | 0.8664 | 0.1632 | 0.2400 | 0.0821 | 0.6723 | 0.0034 | 0.0085 | |
Fisher’s Exact test between groups | ns | ns | 0.1190 | 0.1282 | 0.6279 | 0.5257 | ns |